What does Stella Pharma Corporation do?
Stella Pharma Corporation engages in research and development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its products include SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma,…
What is Stella Pharma Corporation's P/E and P/B ratio?
Stella Pharma Corporation has a P/E ratio of -17.0 and a P/B ratio of 4.85.
What is Stella Pharma Corporation's debt-to-equity ratio?
Stella Pharma Corporation has a debt-to-equity ratio of 0.28.
How much does Stella Pharma Corporation owe compared with what it owns?
Stella Pharma Corporation owes ¥0.40 for every ¥1 it owns (balance sheet Jun 2026), which is low.
What is Stella Pharma Corporation's Positivity rank?
Stella Pharma Corporation is ranked #7,168 of 10,750 companies globally and #3,167 of 3,683 in Japan on PositoAI, with a Positivity Score of 20,257.
Does Stella Pharma Corporation have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for Stella Pharma Corporation.
Where can I read the latest news about Stella Pharma Corporation?
Recent headlines about Stella Pharma Corporation from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Stella Pharma Corporation have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Stella Pharma Corporation's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.